These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33858317)

  • 1. Formulation and Characterization of Febuxostat Loaded Nanostructured Lipid Carriers (NLCs) - Gel for Topical Treatment of Gout.
    Sharma N; Kumar S; Joshi G; Choudhary D
    Recent Pat Nanotechnol; 2022; 16(3):250-258. PubMed ID: 33858317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
    Ali Z; Din FU; Zahid F; Sohail S; Imran B; Khan S; Malik M; Zeb A; Khan GM
    BMC Pharmacol Toxicol; 2022 Nov; 23(1):86. PubMed ID: 36443818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Optimization of Febuxostat-loaded Nano Lipid Carriers Using Full Factorial Design.
    Bhatt S; Sharma JB; Kamboj R; Kumar M; Saini V; Mandge S
    Turk J Pharm Sci; 2021 Feb; 18(1):61-67. PubMed ID: 33633486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers as a strategy for encapsulation of active plant constituents: Formulation and in vitro physicochemical characterizations.
    Chaudhari VS; Murty US; Banerjee S
    Chem Phys Lipids; 2021 Mar; 235():105037. PubMed ID: 33400968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
    Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
    PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.
    Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W
    Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
    Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
    Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem-Loaded Nanostructured Lipid Carriers For Skin and Soft Tissue Infection Caused by Staphylococcus aureus: Formulation, Design, and Evaluation.
    Rajpoot K; Prajapati SK; Malaiya A; Jain R; Jain A
    AAPS PharmSciTech; 2022 Aug; 23(7):241. PubMed ID: 36008695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical phenytoin nanostructured lipid carriers: design and development.
    Motawea A; Borg T; Abd El-Gawad AEH
    Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy.
    Pyo YC; Tran P; Kim DH; Park JS
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111331. PubMed ID: 32906001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model.
    Li J; Yang M; Xu W
    Drug Des Devel Ther; 2018; 12():2241-2248. PubMed ID: 30050285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
    Kawadkar J; Pathak A; Kishore R; Chauhan MK
    Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
    Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
    Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.